172 related articles for article (PubMed ID: 18440103)
1. Plant-expressed HA as a seasonal influenza vaccine candidate.
Shoji Y; Chichester JA; Bi H; Musiychuk K; de la Rosa P; Goldschmidt L; Horsey A; Ugulava N; Palmer GA; Mett V; Yusibov V
Vaccine; 2008 Jun; 26(23):2930-4. PubMed ID: 18440103
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
3. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus.
Li GX; Tian ZJ; Yu H; Jin YY; Hou SH; Zhou YJ; Liu TQ; Hu SP; Tong GZ
Res Vet Sci; 2009 Jun; 86(3):406-13. PubMed ID: 19010505
[TBL] [Abstract][Full Text] [Related]
4. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
Schmeisser F; Vodeiko GM; Lugovtsev VY; Stout RR; Weir JP
Vaccine; 2010 Mar; 28(12):2442-9. PubMed ID: 20074687
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants.
Shoji Y; Farrance CE; Bi H; Shamloul M; Green B; Manceva S; Rhee A; Ugulava N; Roy G; Musiychuk K; Chichester JA; Mett V; Yusibov V
Vaccine; 2009 May; 27(25-26):3467-70. PubMed ID: 19200814
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
[TBL] [Abstract][Full Text] [Related]
7. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
[TBL] [Abstract][Full Text] [Related]
8. The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure.
Kitikoon P; Strait EL; Thacker EL
Vet Microbiol; 2008 Jan; 126(1-3):51-62. PubMed ID: 17719187
[TBL] [Abstract][Full Text] [Related]
9. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza.
Shoji Y; Bi H; Musiychuk K; Rhee A; Horsey A; Roy G; Green B; Shamloul M; Farrance CE; Taggart B; Mytle N; Ugulava N; Rabindran S; Mett V; Chichester JA; Yusibov V
Vaccine; 2009 Feb; 27(7):1087-92. PubMed ID: 19100806
[TBL] [Abstract][Full Text] [Related]
10. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.
Legastelois I; Chevalier M; Bernard MC; de Montfort A; Fouque M; Pilloud A; Serraille C; Devard N; Engel O; Sodoyer R; Moste C
J Virol Methods; 2011 Dec; 178(1-2):129-36. PubMed ID: 21907241
[TBL] [Abstract][Full Text] [Related]
11. Prime-boost immunization with HA/C3d DNA followed by a recombinant pseudorabies virus boost enhanced protective immunity against H3N2 swine influenza virus in mice.
Li GX; Zhou YJ; Yu H; Tian ZJ; Yan LP; Zhang Q; Hu SP; Tong GZ
Res Vet Sci; 2010 Apr; 88(2):345-51. PubMed ID: 19850311
[TBL] [Abstract][Full Text] [Related]
12. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
[TBL] [Abstract][Full Text] [Related]
13. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.
D'Aoust MA; Lavoie PO; Couture MM; Trépanier S; Guay JM; Dargis M; Mongrand S; Landry N; Ward BJ; Vézina LP
Plant Biotechnol J; 2008 Dec; 6(9):930-40. PubMed ID: 19076615
[TBL] [Abstract][Full Text] [Related]
14. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
[TBL] [Abstract][Full Text] [Related]
15. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity.
de Vries JJ; Bungener L; Ter Veer W; van Alphen L; van der Ley P; Wilschut J; Huckriede A
Vaccine; 2009 Feb; 27(6):947-55. PubMed ID: 19059296
[TBL] [Abstract][Full Text] [Related]
17. A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge.
Tian ZJ; Zhou GH; Zheng BL; Qiu HJ; Ni JQ; Yang HL; Yin XN; Hu SP; Tong GZ
Vet Immunol Immunopathol; 2006 Jun; 111(3-4):211-8. PubMed ID: 16621018
[TBL] [Abstract][Full Text] [Related]
18. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
[TBL] [Abstract][Full Text] [Related]
19. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.
Okamoto S; Matsuura M; Akagi T; Akashi M; Tanimoto T; Ishikawa T; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2009 Sep; 27(42):5896-905. PubMed ID: 19647814
[TBL] [Abstract][Full Text] [Related]
20. Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice.
Hovden AO; Cox RJ; Haaheim LR
Scand J Immunol; 2005 Jul; 62(1):36-44. PubMed ID: 16092921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
